Tempest Therapeutics Inc. (TPST)
ADC Therapeutics SA (ADCT)
New Form 8-K - ADC Therapeutics SA Filed: 2025-06-12 AccNo: 0000950103-25-007282 Size: 473 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.05: Cost Associated with Exit or Disposal Activities Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Ionis Pharmaceuticals Inc (IONS)
New Form 8-K - IONIS PHARMACEUTICALS INC Filed: 2025-06-12 AccNo: 0001140361-25-022267 Size: 168 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Brookdale Senior Living Inc (BKD)
Baxter International Inc (BAX)
New Form 8-K - BAXTER INTERNATIONAL INC Filed: 2025-06-12 AccNo: 0001193125-25-139604 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item …
GSK plc (GLAXF)
Citius Pharmaceuticals Inc. (CTXR)
Fortrea Holdings Inc (FTRE)
New Form 8-K - Fortrea Holdings Inc. Filed: 2025-06-12 AccNo: 0001193125-25-139600 Size: 510 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: …